Combination therapy IO + Chemo in Triple Negative Breast Cancer Schmid 2

GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). The excellent faculty in these videos discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.